Log in to save to my catalogue

Use of cangrelor for complex percutaneous coronary intervention in the context of concomitant severe...

Use of cangrelor for complex percutaneous coronary intervention in the context of concomitant severe...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11108589

Use of cangrelor for complex percutaneous coronary intervention in the context of concomitant severe aortic stenosis: a case series

About this item

Full title

Use of cangrelor for complex percutaneous coronary intervention in the context of concomitant severe aortic stenosis: a case series

Publisher

UK: Oxford University Press

Journal title

European heart journal : case reports, 2024-05, Vol.8 (5), p.ytae237

Language

English

Formats

Publication information

Publisher

UK: Oxford University Press

More information

Scope and Contents

Contents

Abstract
Background
There is a growing need for percutaneous coronary intervention (PCI) to be performed within the same transcatheter aortic valve implantation (TAVI) procedure. In such cases, cangrelor, a fast-acting intravenous P2Y12-inhibitor with a short offset, is potential clinical utility to minimize bleeding and vascular complication...

Alternative Titles

Full title

Use of cangrelor for complex percutaneous coronary intervention in the context of concomitant severe aortic stenosis: a case series

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11108589

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11108589

Other Identifiers

ISSN

2514-2119

E-ISSN

2514-2119

DOI

10.1093/ehjcr/ytae237

How to access this item